Affimed to Present at the 2017 Wells Fargo Healthcare Conference - Boston
September 04 2017 - 5:01AM
Heidelberg, Germany, September 4, 2017 - Affimed N.V. (Nasdaq:
AFMD), a clinical stage biopharmaceutical company focused on
discovering and developing highly targeted cancer immunotherapies,
announced today that Dr. Adi Hoess, CEO, will present at the 2017
Wells Fargo Healthcare Conference on Thursday, September 7, 2017 at
9:25 a.m. (ET) in Boston. A live webcast of the conference
presentation can be accessed through the "Events" section on the
"Investors & Media" page of the Affimed website at
http://www.affimed.com/events.php. A replay of the presentation
will be available from Affimed's website for 30 days following the
conference. About Affimed N.V. Affimed (Nasdaq: AFMD)
engineers targeted immunotherapies, seeking to cure patients by
harnessing the power of innate and adaptive immunity (NK and T
cells). We are developing single and combination therapies to treat
cancers and other life-threatening diseases. For more information,
please visit www.affimed.com. IR Contact: Caroline Stewart,
Head IR Phone: +1 347 394 6793 E-Mail: IR@affimed.com or
c.stewart@affimed.com Media Contact: Anca Alexandru, Head of
Communications, EU IR Phone: +49 6221 64793341 E-Mail:
a.alexandru@affimed.com
Affimed NV (NASDAQ:AFMD)
Historical Stock Chart
From Mar 2024 to Apr 2024
Affimed NV (NASDAQ:AFMD)
Historical Stock Chart
From Apr 2023 to Apr 2024
